Ginkgo Bioworks Holdings (DNA) Receivables - Other (2021 - 2025)

Ginkgo Bioworks Holdings (DNA) has 5 years of Receivables - Other data on file, last reported at $11.2 million in Q3 2025.

• For the quarter ending Q3 2025, Receivables - Other rose 38.27% year-over-year to $11.2 million; the trailing twelve-month figure through Sep 2025 stood at $11.2 million (up 38.27% YoY), and the FY2023 full-year result was $10.1 million, up 547.02% from the prior year.
• Receivables - Other for Q3 2025 stood at $11.2 million, up from $10.9 million in the prior quarter.
• Across five years, Receivables - Other topped out at $11.2 million in Q3 2025 and bottomed at $300000.0 in Q2 2021.
• The 5-year median for Receivables - Other is $6.3 million (2021), against an average of $6.1 million.
• Peak annual rise in Receivables - Other reached 2066.67% in 2022, while the deepest fall reached 65.37% in 2022.
• A 5-year view of Receivables - Other shows it stood at $6.0 million in 2021, then plunged by 65.37% to $2.1 million in 2022, then soared by 382.1% to $10.1 million in 2023, then decreased by 19.8% to $8.1 million in 2024, then soared by 38.27% to $11.2 million in 2025.
• The last three Receivables - Other figures came in at $11.2 million (Q3 2025), $10.9 million (Q2 2025), and $8.1 million (Q3 2024), per Business Quant data.

Peer Comparison